Study of LM-364 alone or with other cancer treatments for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This study tests an investigational drug called LM-364, either by itself or combined with other cancer therapies, in people with advanced solid tumors. The goal is to see if the drug is safe and effective, and it may offer a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have an advanced solid tumor (cancer that has spread or cannot be removed).
- You are able to take care of yourself (ECOG score 0-1).
- Your doctor expects you to live at least 3 more months.
- Your organs and blood counts are working well enough (checked by tests).
- You have not had other cancer treatment within the last 28 days, and side effects from previous treatments have mostly gone away.
- You are not pregnant or breastfeeding, and you are willing to use birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, LM-24C5, for people with advanced solid tumors that have come back or not responded to treatment. It may be an option if your tumor has a specific marker called CEACAM5.
This trial tests a new drug called LM-168, either alone or combined with another cancer treatment, for people with advanced solid tumors that have not responded to standard therapies. The goal is to see if it can shrink tumors or slow their growth.
This trial tests a new drug called LPM6690176 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects the body.
This is an early-stage trial testing a new cancer treatment called JLM019 in patients with advanced solid tumors or lymphomas that haven't responded to other treatments. The study aims to find the right dose and see how well the drug works and how patients tolerate it.
This trial tests a new drug called LM-364, either by itself or combined with other anti-cancer treatments. The goal is to see if it can help people with advanced solid tumors that have not responded to standard therapies.
This trial tests an experimental drug called LM-350 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug can shrink tumors or slow their growth.
Hear when a new Advanced Solid Tumor Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.